Alexandra Moens, PharmD, is the director of product marketing at H1. She is a thought leader and frequent speaker on the need for diversity and performance data in clinical trials, as well as the impact it has on clinical decision-making. As a pharmacist with an innovative business mindset, Alexandra makes an impact on the life of patients by working on improved solutions, diversity implementation, and working on enhanced clinical strategies. Her scientific and business experience has taught her to make fast but data-driven decisions to successfully manage a portfolio strategy in the evolving pharmaceutical industry. Alexandra has worked closely together with clinical, data intelligence, and medical affairs teams of pharma and biotech companies across the globe to help roll out new clinical and medical methodologies and strategies.
Leaders need a framework to identify, understand, effectively address diversity gaps, and measure improvement across the continuum of care. A data-driven approach can provide valuable insights into demographic trends, disparities in healthcare access and outcomes, and the underlying factors contributing to these discrepancies.
The healthcare industry is sitting on a wealth of data gathered from electronic health records, commercial pharmacies, health systems and payers, and health tech companies. So much that it makes up one-third of the world’s data. Pharmaceutical companies need to tap into this type of data to build inclusive clinical trials,
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.